<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03346512</url>
  </required_header>
  <id_info>
    <org_study_id>CHUB-perfusion</org_study_id>
    <nct_id>NCT03346512</nct_id>
  </id_info>
  <brief_title>Considerations on the Transfusion Threshold in Cardiac Surgery</brief_title>
  <official_title>Considerations on the Transfusion Threshold in Cardiac Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Pierre Wauthy</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Brugmann University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a retrospective observational study of the transfusion threshold in cardiac surgery.

      There is controversy in the literature regarding the transfusion threshold to be adopted,
      especially in a patient who has undergone cardiac surgery. Some authors suggest that the
      transfusion should be done in a restrictive way when a certain threshold in hemoglobin is
      reached, in order to avoid the risks it implies, especially infectious.This threshold is very
      controversial and remains to be defined (variations in the literature from 7g / dL to 9g /
      dL). Other authors conclude that there is no superiority of a restrictive transfusion
      compared to a more liberal transfusion, with regard to the morbidity or medical costs.

      It is therefore interesting to study, in a retrospective manner, the global and
      multidisciplinary management of patients who have undergone a cardiac surgery within the CHU
      Brugmann hospital, to analyze if they have been adequately transfused.
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">February 2016</start_date>
  <completion_date type="Anticipated">December 2017</completion_date>
  <primary_completion_date type="Anticipated">December 2017</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Hemoglobin rate</measure>
    <time_frame>Baseline (just before cardiac surgery)</time_frame>
    <description>Hemoglobin rate</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Hemoglobin rate</measure>
    <time_frame>One day after surgery (J1)</time_frame>
    <description>Hemoglobin rate</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Hemoglobin rate</measure>
    <time_frame>Two days after surgery (J2)</time_frame>
    <description>Hemoglobin rate</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Hemoglobin rate</measure>
    <time_frame>Five days after surgery (J5)</time_frame>
    <description>Hemoglobin rate</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Hematocrit rate</measure>
    <time_frame>Baseline (just before cardiac surgery)</time_frame>
    <description>Hematocrit rate</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Hematocrit rate</measure>
    <time_frame>One day after surgery (J1)</time_frame>
    <description>Hematocrit rate</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Hematocrit rate</measure>
    <time_frame>Two days after surgery (J2)</time_frame>
    <description>Hematocrit rate</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Hematocrit rate</measure>
    <time_frame>Five days after surgery (J5)</time_frame>
    <description>Hematocrit rate</description>
  </primary_outcome>
  <primary_outcome>
    <measure>International Normalized Ratio (INR)</measure>
    <time_frame>Baseline (just before cardiac surgery)</time_frame>
    <description>Coagulation indicator</description>
  </primary_outcome>
  <primary_outcome>
    <measure>International Normalized Ratio (INR)</measure>
    <time_frame>One day after surgery (J1)</time_frame>
    <description>Coagulation indicator</description>
  </primary_outcome>
  <primary_outcome>
    <measure>International Normalized Ratio (INR)</measure>
    <time_frame>Two days after surgery (J2)</time_frame>
    <description>Coagulation indicator</description>
  </primary_outcome>
  <primary_outcome>
    <measure>International Normalized Ratio (INR)</measure>
    <time_frame>Five days after surgery (J5)</time_frame>
    <description>Coagulation indicator</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Creatinin rate</measure>
    <time_frame>Baseline (just before cardiac surgery)</time_frame>
    <description>Renal function indicator</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Creatinin rate</measure>
    <time_frame>One day after surgery (J1)</time_frame>
    <description>Renal function indicator</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Creatinin rate</measure>
    <time_frame>Two days after surgery (J2)</time_frame>
    <description>Renal function indicator</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Creatinin rate</measure>
    <time_frame>Five days after surgery (J5)</time_frame>
    <description>Renal function indicator</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Total amount of blood perfusions</measure>
    <time_frame>Five days after surgery (J5)</time_frame>
    <description>Total amount of blood perfusions</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Liquid balance</measure>
    <time_frame>One day after surgery</time_frame>
    <description>Ratio between total fluid intake (perfusion) and loss (blood and urine)</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">852</enrollment>
  <condition>Cardiac Surgery</condition>
  <arm_group>
    <arm_group_label>Cardiac surgery</arm_group_label>
    <description>Patients having undergone cardiac surgery (other than the placement of a pacemaker or defibrillator) within the CHU Brugmann hospital between 2006 and 2015</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Cardiac surgery</intervention_name>
    <description>Cardiac surgery</description>
    <arm_group_label>Cardiac surgery</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients having undergone cardiac surgery (other than the placement of a pacemaker or
        defibrillator) within the CHU Brugmann hospital between 2006 and 2015
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

        - Patients having undergone cardiac surgery (other than the placement of a pacemaker or
        defibrillator) within the CHU Brugmann hospital between 2006 and 2015

        Exclusion Criteria:
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Kenza Bradly, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>CHU Brugmann</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>CHU Brugmann</name>
      <address>
        <city>Brussels</city>
        <zip>1020</zip>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Belgium</country>
  </location_countries>
  <verification_date>November 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 15, 2017</study_first_submitted>
  <study_first_submitted_qc>November 15, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">November 17, 2017</study_first_posted>
  <last_update_submitted>November 15, 2017</last_update_submitted>
  <last_update_submitted_qc>November 15, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">November 17, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Brugmann University Hospital</investigator_affiliation>
    <investigator_full_name>Pierre Wauthy</investigator_full_name>
    <investigator_title>Head of clinic</investigator_title>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

